Top Markets
Coin of the day
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Rang in Aktien #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Aktienkurs
$0.2301
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$228.81K
Veränderung (1 Tag)
-17.82%
Veränderung (1 Jahr)
95,775.00%
Land
US
Handel The Greater Cannabis Company, Inc. (GCAN)

Kategorie

Dividendenrendite-Verlauf für The Greater Cannabis Company, Inc. (GCAN)
Dividendenrendite (TTM) von The Greater Cannabis Company, Inc. (Aktienkürzel: GCAN) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für The Greater Cannabis Company, Inc. (GCAN) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber